TrendsinPsychotropicPolypharmacy AmongYouthsEnrolledinOhio Medicaid,2002-2008
暂无分享,去创建一个
[1] M. Olfson,et al. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. , 2012, Archives of general psychiatry.
[2] R. Aparasu,et al. The definition and prevalence of pediatric psychotropic polypharmacy. , 2011, Psychiatric services.
[3] M. Riddle,et al. Antipsychotic Treatment Among Youth in Foster Care , 2011, Pediatrics.
[4] M. Olfson,et al. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.
[5] T. Boaz,et al. Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state Medicaid program. , 2010, Clinical therapeutics.
[6] J. Lieberman,et al. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state. , 2009, Psychiatric services.
[7] Barbara Napolitano,et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. , 2009, JAMA.
[8] M. Olfson,et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. , 2009, Health affairs.
[9] C. Feudtner,et al. State Variation in Psychotropic Medication Use by Foster Care Children With Autism Spectrum Disorder , 2009, Pediatrics.
[10] C. Correll,et al. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. , 2009, Schizophrenia bulletin.
[11] R. McIntyre,et al. Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study. , 2009, The Journal of clinical psychiatry.
[12] R. McIntyre,et al. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. , 2008, Archives of pediatrics & adolescent medicine.
[13] J. Oldham,et al. When is antipsychotic polypharmacy supported by research evidence? Implications for QI. , 2008, Joint Commission journal on quality and patient safety.
[14] D. Safer,et al. Psychotropic Medication Patterns Among Youth in Foster Care , 2008, Pediatrics.
[15] Jill U. Adams,et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[16] C. Arango,et al. Antipsychotic-related abnormal involuntary movements and metabolic and endocrine side effects in children and adolescents. , 2007, Journal of child and adolescent psychopharmacology.
[17] S. Benjamin,et al. Dystonia with combined antipsychotic and stimulant treatment. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[18] C. Correll. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[19] Brett W Sharp. Cmap ADHD and comorbid aggression algorithm. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[20] J. Swanson,et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[21] M. Monuteaux,et al. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[22] Imke H. Bartelink,et al. Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic Considerations , 2006, Clinical pharmacokinetics.
[23] B. Kerker,et al. Mental health needs and treatment of foster youth: barriers and opportunities. , 2006, The American journal of orthopsychiatry.
[24] M. Crismon,et al. Trends in the use of typical and atypical antipsychotics in children and adolescents. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[25] E. Benjamin,et al. Stimulant-atypical antipsychotic interaction and acute dystonia. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[26] H. Pincus,et al. Concomitant pharmacotherapy among youths treated in routine psychiatric practice. , 2005, Journal of child and adolescent psychopharmacology.
[27] P. Owens,et al. Multiple psychotropic medication use for youths: a two-state comparison. , 2005, Journal of child and adolescent psychopharmacology.
[28] S. Gaehde,et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database , 2005, Pharmacoepidemiology and drug safety.
[29] R. Surles,et al. Using best practices to manage psychiatric medications under Medicaid. , 2004, Psychiatric services.
[30] A. Localio,et al. Placement Changes and Emergency Department Visits in the First Year of Foster Care , 2004, Pediatrics.
[31] L. Leslie,et al. Outpatient mental health services for children in foster care: a national perspective. , 2004, Child abuse & neglect.
[32] S. Stahl. Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? , 2004, The international journal of neuropsychopharmacology.
[33] B. Vitiello,et al. National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge , 2004, Journal of attention disorders.
[34] A. Localio,et al. Placement stability and mental health costs for children in foster care. , 2004, Pediatrics.
[35] A. Garland,et al. Racial/ethnic disparities in mental health service use among children in foster care , 2003 .
[36] D. Safer,et al. Concomitant psychotropic medication for youths. , 2003, The American journal of psychiatry.
[37] M. Jellinek. Mirror, mirror on the wall: are we prescribing the right psychotropic medications to the right children using the right treatment plan? , 2003, Archives of pediatrics & adolescent medicine.
[38] M. Weissman,et al. National trends in the use of psychotropic medications by children. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.
[39] R. Schweitzer,et al. "Real world" atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. , 2002, Schizophrenia bulletin.
[40] G. Simpson,et al. Psychopharmacology: rational and irrational polypharmacy. , 2001, Psychiatric services.
[41] K. Soeken,et al. Mental health services for youths in foster care and disabled youths. , 2001, American journal of public health.
[42] K. Kelleher,et al. Mental health care utilization and expenditures by children in foster care. , 2000, Archives of pediatrics & adolescent medicine.
[43] J. Woolston. Combined pharmacotherapy: pitfalls of treatment. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[44] D. Connor,et al. Combined pharmacotherapy in children and adolescents in a residential treatment center. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[45] J. Biederman,et al. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[46] A. Bergman,et al. Children in foster care in the state of Washington. Health care utilization and expenditures. , 1994, JAMA.